Cozad Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.47M | Sell |
15,945
-475
| -3% | -$105K | 0.27% | 88 |
|
|
2025
Q4 | $3.75M | Sell |
16,420
-930
| -5% | -$212K | 0.29% | 85 |
|
|
2025
Q3 | $4.02M | Sell |
17,350
-300
| -2% | -$61.1K | 0.32% | 78 |
|
|
2025
Q2 | $3.28M | Sell |
17,650
-647
| -4% | -$120K | 0.29% | 86 |
|
|
2025
Q1 | $3.83M | Buy |
18,297
+177
| +1% | +$34.4K | 0.38% | 71 |
|
|
2024
Q4 | $3.22M | Sell |
18,120
-536
| -3% | -$98.5K | 0.3% | 87 |
|
|
2024
Q3 | $3.68M | Sell |
18,656
-350
| -2% | -$65.3K | 0.35% | 75 |
|
|
2024
Q2 | $3.26M | Buy |
19,006
+378
| +2% | +$62.6K | 0.33% | 81 |
|
|
2024
Q1 | $3.39M | Sell |
18,628
-29
| -0.2% | -$5K | 0.35% | 76 |
|
|
2023
Q4 | $2.89M | Sell |
18,657
-40
| -0.2% | -$5.83K | 0.33% | 83 |
|
|
2023
Q3 | $2.79M | Sell |
18,697
-136
| -0.7% | -$20K | 0.36% | 76 |
|
|
2023
Q2 | $2.54M | Sell |
18,833
-867
| -4% | -$127K | 0.32% | 89 |
|
|
2023
Q1 | $3.14M | Buy |
19,700
+152
| +0.8% | +$23.2K | 0.42% | 67 |
|
|
2022
Q4 | $3.16M | Buy |
19,548
+1,329
| +7% | +$204K | 0.44% | 64 |
|
|
2022
Q3 | $2.44M | Sell |
18,219
-1,189
| -6% | -$171K | 0.4% | 69 |
|
|
2022
Q2 | $2.97M | Sell |
19,408
-149
| -0.8% | -$22.8K | 0.46% | 56 |
|
|
2022
Q1 | $3.17M | Buy |
19,557
+2,687
| +16% | +$390K | 0.44% | 61 |
|
|
2021
Q4 | $2.28M | Sell |
16,870
-240
| -1% | -$28.4K | 0.32% | 80 |
|
|
2021
Q3 | $1.85M | Sell |
17,110
-933
| -5% | -$107K | 0.29% | 92 |
|
|
2021
Q2 | $2.03M | Sell |
18,043
-287
| -2% | -$32.3K | 0.32% | 85 |
|
|
2021
Q1 | $1.98M | Buy |
18,330
+1,152
| +7% | +$123K | 0.32% | 82 |
|
|
2020
Q4 | $1.84M | Sell |
17,178
-73
| -0.4% | -$7.01K | 0.33% | 80 |
|
|
2020
Q3 | $1.51M | Buy |
17,251
+167
| +1% | +$15.7K | 0.29% | 99 |
|
|
2020
Q2 | $1.68M | Buy |
17,084
+516
| +3% | +$45.4K | 0.34% | 84 |
|
|
2020
Q1 | $1.26M | Sell |
16,568
-1,900
| -10% | -$162K | 0.44% | 71 |
|
|
2019
Q4 | $1.64M | Sell |
18,468
-1,275
| -6% | -$106K | 0.44% | 74 |
|
|
2019
Q3 | $1.5M | Sell |
19,743
-39,521
| -67% | -$2.71M | 0.43% | 74 |
|
|
2019
Q2 | $4.31M | Sell |
59,264
-3,218
| -5% | -$253K | 1.25% | 18 |
|
|
2019
Q1 | $5.04M | Buy |
62,482
+7,038
| +13% | +$576K | 1.52% | 14 |
|
|
2018
Q4 | $5.11M | Sell |
55,444
-12,445
| -18% | -$1.09M | 1.77% | 9 |
|
|
2018
Q3 | $6.42M | Buy |
67,889
+5,958
| +10% | +$565K | 1.88% | 8 |
|
|
2018
Q2 | $5.74M | Buy |
+61,931
| New | +$6.05M | 1.79% | 11 |
|
Other funds holding ABBV
VCM
VPM
Cozad Asset Management's ABBV Position: Q1 2026 in Review
Cozad Asset Management reduced its AbbVie (ABBV) stake by 2.9% in Q1 2026, selling an estimated $105K and leaving 15,945 shares worth $3.47M. The position accounts for 0.27% of the portfolio, ranked #88.
Cozad Asset Management first reported a position in ABBV in Q2 2018 and has held it in 32 quarters since. The position peaked at $6.42M in Q3 2018. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Cozad Asset Management held 15,945 shares of AbbVie worth $3.47M as of Q1 2026.
- Cozad Asset Management sold 475 AbbVie shares in Q1 2026, an estimated $105K.
- AbbVie made up 0.27% of Cozad Asset Management's portfolio in Q1 2026, its #88 holding.
- Cozad Asset Management first reported a position in AbbVie in Q2 2018 and has held it in 32 quarters since.
- Cozad Asset Management's AbbVie position peaked at $6.42M in Q3 2018.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Cozad Asset Management's 13F filing for Q1 2026, filed 28 May 2026.